Basic Information
Basic information for AC090825.1-214-21aa
Peptide Name AC090825.1-214-21aa
Genome Position chr15:99813009-99813071[+]
Species Human
Peptide Sequence MITAHGSLHLLGSILLPQPSK
Peptide Length 21
Unique No (AC090825.1-216-21aa,AC090825.1-205-21aa,AC090825.1-202-21aa,AC090825.1-206-21aa,AC090825.1-215-21aa,AC090825.1-209-21aa,AC090825.1-207-21aa,AC090825.1-203-21aa,AC090825.1-210-21aa,AC090825.1-213-21aa,AC090825.1-217-21aa-1,AC090825.1-201-21aa,AC090825.1-211-21aa)
Grand Average of Hydropathicity 0.5143
Relative Molecular Mass 2573.98
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000259363;AC090825.1
Transcript ID/Name ENST00000665821;AC090825.1-214
Transcript Length 991
Coding Ability 0.4036
DNA Sequence Corresponding to Peptide ATGATCACAGCTCACGGTAGCCTCCACCTTCTGGGCTCAATCCTCCTACCTCAGCCTTCCAAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :